[조사자료] 세계의 차세대 시퀀싱 (NGS) 시장 2024-2030 : 기술별 (WGS, 타겟 시퀀싱, 리시퀀싱), 제품별 (플랫폼, 소모품), 용도별, 워크플로우별, 최종 용도별, 지역별

■ 영문 제목 : Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (WGS, Targeted Sequencing & Resequencing), By Product (Platform, Consumables), By Application, By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JAN048 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 11월 ■ 페이지수 : 300 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 차세대 시퀀싱 (NGS) 시장의 성장 및 동향
Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 차세대 시퀀싱 (NGS) 시장 규모는 2024년부터 2030년까지 21.12%의 CAGR을 기록하며 2030년까지 312억 6천만 달러에 달할 것으로 예측됩니다. 차세대 시퀀싱 (NGS)은 확장성, 대용량, 빠른 속도로 전체 유전체 염기서열을 구축할 수 있는 병렬 처리 기술입니다. 또한, 헬스케어 산업에서 NGS는 의료 검사 연구, 스크리닝, 질병 진단에 점차적으로 도입되고 있습니다. 개인화 의료에서는 신약 개발 연구 과정을 가속화하기 위해 자주 활용되고 있습니다.

RNA 시퀀싱, 전장 유전체 시퀀싱, 전 엑솜 표적 시퀀싱 등 다양한 잠재력을 가진 시퀀싱 기법은 포괄적인 시료 분석을 위해 연구자들이 많이 활용하고 있습니다. 기존의 싱어 시퀀싱 기술에 비해 NGS는 비용이 저렴하고 DNA 시퀀싱의 처리량이 높습니다. 사전 시퀀싱 프로토콜, 사후 시퀀싱 프로토콜, 데이터 분석의 자동화가 진행되고 있다는 점도 NGS 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. 유전자 수준의 의학 분석을 통한 개인 맞춤형 의료 개발을 위한 새로운 플랫폼의 활용도 중요한 요인으로 예측 기간 동안 NGS의 수요를 증가시킬 것으로 예상됩니다.

이 외에도 개인 맞춤형 의료 및 동반 진단의 발전, 클라우드 컴퓨팅의 발전, 데이터 통합 등 시퀀싱 산업에서 볼 수 있는 중요한 성장 추세가 있습니다. 또한, 게놈 및 프로테오믹스 데이터에 대한 접근성이 높아짐에 따라 이 시장은 예측 기간 동안 잠재적으로 높은 가치의 성장 경로와 기회를 제공할 것으로 보입니다. GLOBOCAN 2020에 따르면, 2020년 신규 암 환자 수는 1,92,92,789명이며, 2020년에는 2,88,87,940명으로 증가할 것으로 예상되고 있습니다. 이러한 암 환자 수의 대폭적인 증가는 궁극적으로 NGS 시장의 성장을 가속화하는 암 연구를 활성화시킬 것으로 추정됩니다.

NGS 진단 기술은 바이러스의 유전체 염기서열을 결정하고 돌연변이를 이해하는 데 있어 과학자들을 도울 수 있는 잠재력을 가지고 있습니다. 또한, 코로나19 사태를 통해 전 세계 정부는 기업 부문과 협력하여 NGS 기술을 실행 가능한 진단 도구로 시장에 도입하고 있습니다. 미국 식품의약국(FDA)은 2020년 6월, 차세대 시퀀싱 (NGS) 기술을 이용한 최초의 코로나19 진단을 위해 일루미나(Illumina Inc.)에 긴급사용허가를 부여했으며, SARS-CoV-2 RNA의 정량적 식별을 위한 일루미나 COVIDSeq 테스트는 FDA의 승인을 받았습니다. 그 결과, 전염병이 유행할 때 차세대 시퀀싱 (NGS) 기술의 활용이 증가할 것으로 예상됩니다.

차세대 시퀀싱 (NGS) 시장 보고서 하이라이트

- 용도별로는 종양학 부문이 2023년 27.31%의 가장 큰 매출 점유율을 차지했습니다. 이 부문의 성장은 암의 유병률 증가와 시퀀싱 기술의 발전에 기인합니다.

- 학술 연구 부문은 예측 기간 동안 이러한 연구 기관에서 용도 기반 활용이 증가하고 종양학 연구가 증가함에 따라 크게 성장할 것으로 예상됩니다. 또한, 치료제, 종양학 및 게놈 연구를 위한 연구 개발의 발전이 시장 성장에 기여했습니다.

- 아시아 태평양 지역은 의료 인프라의 광범위한 발전, 선진 기술 도입에 대한 각국의 적극적인 노력, 주요 기업의 존재 등으로 인해 예측 기간 동안 시장이 크게 성장할 것으로 예상됩니다.

- 북미는 2023년 49.35%의 점유율로 시장을 지배했습니다. 높은 R&D 투자가 존재하고 기술적으로 진보된 헬스케어 연구 프레임워크가 존재하기 때문에 이 지역의 WGS 개발도 예측 기간 동안 북미 NGS 시장 성장의 중요한 요인으로 작용할 것으로 예상되고 있습니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 변수/동향/범위
4. 세계의 차세대 시퀀싱 (NGS) 시장 규모 :기술별 비즈니스 분석
5. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 제품별 비즈니스 분석
6. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 용도별 비즈니스 분석
7. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 워크플로별 비즈니스 분석
8. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 최종 용도별 비즈니스 분석
9. 세계의 차세대 시퀀싱 (NGS) 시장 규모 : 지역별 예측 및 동향 분석
10. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.3.4.1 Primary Interviews: Statistics
1.3.4.1.1 Geographical Distribution Of Primary Interviews
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Objectives
1.6.1 Objective 1
1.6.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Cost Structure Analysis
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.1.1 Market Influencer Analysis
3.4 Procedure Cost Analysis
3.5 List Of Key End Users
3.5.1 By Type
3.5.2 By Product
3.5.3 By U.S. State
3.6 Technology Overview
3.6.1 Technology Timeline
3.7 Impact Of Covid-19 Pandemic
3.7.1 Impact On The Supply Chain
3.7.2 Association Of Covid-19 With Ngs
3.8 Market Trends And Outlook
3.9 Market Segmentation And Scope
3.10 Market Dynamics
3.10.1 Market Driver Analysis
3.10.1.1 Exponentially Decreasing Costs For Genetic Sequencing
3.10.1.2 Development Of Companion Diagnostics And Personalized Medicine
3.10.1.3 Rise In Competition Among Prominent Market Entities
3.10.1.4 Rising Clinical Opportunity For Ngs Technology
3.10.1.5 Technological Advancements In Cloud Computing And Data Integration
3.10.1.6 Growing Healthcare Expenditure Supporting Development Of Effective Diagnostic & Therapeutic Procedures For Cancer
3.10.1.7 Increasing Prevalence Of Cancer
3.10.2 Market Restraint Analysis
3.10.2.1 Lack Of Computational Efficiency For Data Management
3.10.2.2 Non–Value-Based Ngs Reimbursement Policy And Regulation Status
3.10.2.3 Challenges Associated With Ngs Implementation
3.11 Business Environment Analysis
3.11.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
3.11.2 Porter’s Five Forces Analysis
3.12 Major Deals And Strategic Alliances Analysis
3.12.1 Joint Ventures
3.12.2 Mergers & Acquisitions
3.12.3 Licensing & Partnerships
3.12.4 Technology Collaborations
Chapter 4 Technology Business Analysis
4.1 Next Generation Sequencing Market: Technology Movement Analysis
4.2 Targeted Sequencing & Resequencing
4.2.1 Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.2.1.1 Dna-Based Targeted Sequencing & Resequencing
4.2.1.1.1 Dna-Based Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.2.1.2 Rna-Based Targeted Sequencing & Resequencing
4.2.1.2.1 Rna -Based Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Whole Genome Sequencing
4.3.1 Whole Genome Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Whole Exome Sequencing
4.4.1 Whole Exome Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.5 Others
4.5.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Product Business Analysis
5.1 Next Generation Sequencing Market: Product Movement Analysis
5.2 Platforms
5.2.1 Platforms Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.1.1 Sequencing
5.2.1.1.1 Sequencing Platforms Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.1.2 Data Analysis
5.2.1.2.1 Data Analysis Platforms Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 Consumables
5.3.1 Consumables Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.2 Sample Preparation
5.3.2.1 Sample Preparation Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.3 Target Enrichment
5.3.3.1 Target Enrichment Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.4 Others
5.3.4.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Application Business Analysis
6.1 Next Generation Sequencing Market: Application Movement Analysis
6.2 Oncology
6.2.1 Oncology Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2 Diagnostics & Screening
6.2.2.1 Diagnostics & Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.2 Oncology Screening
6.2.2.2.1 Oncology Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.2.2 Sporadic Cancer Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.2.3 Inherited Cancer Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.3 Companion Diagnostics
6.2.2.3.1 Companion Diagnostics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.2.4 Other Diagnostics
6.2.2.4.1 Other Diagnostics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.2.3 Research Studies
6.2.3.1 Research Studies Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Clinical Investigation
6.3.1 Clinical Investigation Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.2 Infectious Diseases
6.3.2.1 Infectious Diseases Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.3 Idiopathic Diseases
6.3.3.1 Idiopathic Diseases Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.4 Inherited Diseases
6.3.4.1 Inherited Diseases Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.5 Non-Communicable/Other Diseases
6.3.5.1 Non-Communicable/Other Diseases Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Reproductive Health
6.4.1 Reproductive Health Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.2 Nipt
6.4.2.1 Nipt Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.2.2 Aneuploidy
6.4.2.2.1 Aneuploidy Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.2.3 Microdeletions
6.4.2.3.1 Microdeletions Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.3 Pgt
6.4.3.1 Pgt Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.4 Newborn Genetic Screening
6.4.4.1 Newborn Genetic Screening Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4.5 Single Gene Analysis
6.4.5.1 Single Gene Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.5 Hla Typing/Immune System Monitoring
6.5.1 Hla Typing/Immune System Monitoring Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.6 Metagenomics, Epidemiology & Drug Development
6.6.1 Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.7 Agrigenomics & Forensics
6.7.1 Agrigenomics & Forensics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.8 Consumer Genomics
6.8.1 Consumer Genomics Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Workflow Business Analysis
7.1 Next Generation Sequencing Market: Workflow Movement Analysis
7.2 Presequencing
7.2.1 Pre-Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.1.1 Ngs Library Preparation Kits
7.2.1.1.1 Ngs Library Preparation Kits Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.1.2 Semiautomated Library Preparation
7.2.1.2.1 Semiautomated Library Preparation Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.1.3 Automated Library Preparation
7.2.1.3.1 Automated Library Preparation Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.3 Sequencing
7.3.1 Sequencing Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4 Data Analysis
7.4.1 Data Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4.2 Primary Data Ngs Analysis
7.4.2.1 Primary Data Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4.3 Secondary Data Analysis
7.4.3.1 Secondary Data Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.4.4 Tertiary Data Analysis
7.4.4.1 Tertiary Data Analysis Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 8 End-Use Business Analysis
8.1 Next Generation Sequencing Market: End-Use Movement Analysis
8.2 Academic Research
8.2.1 Academic Research Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.3 Clinical Research
8.3.1 Clinical Research Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.4 Hospitals & Clinics
8.4.1 Hospitals & Clinics Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.5 Pharmaceutical & Biotech Entities
8.5.1 Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2018 – 2030 (USD Million)
8.6 Other Users
8.6.1 Other Users Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 9 Next Generation Sequencing Market: Regional Estimates And Trend Analysis, By Product, Technology, Application, Workflow, & End-Use
9.1 North America
9.1.1 North America Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.1.2 U.S.
9.1.2.1 Key Country Dynamics
9.1.2.2 Target Disease Prevalence
9.1.2.3 Competitive Scenario
9.1.2.4 Regulatory Framework
9.1.2.5 Reimbursement Scenario
9.1.2.6 U.S. Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.1.3 Canada
9.1.3.1 Key Country Dynamics
9.1.3.2 Target Disease Prevalence
9.1.3.3 Competitive Scenario
9.1.3.4 Regulatory Framework
9.1.3.5 Reimbursement Scenario
9.1.3.6 Canada Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2 Europe
9.2.1 Europe Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.2 Uk
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 Competitive Scenario
9.2.2.4 Regulatory Framework
9.2.2.5 Reimbursement Scenario
9.2.2.6 Uk Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.3 Germany
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Competitive Scenario
9.2.3.4 Regulatory Framework
9.2.3.5 Reimbursement Scenario
9.2.3.6 Germany Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.4 France
9.2.4.1 Key Country Dynamics
9.2.4.2 Target Disease Prevalence
9.2.4.3 Competitive Scenario
9.2.4.4 Regulatory Framework
9.2.4.5 Reimbursement Scenario
9.2.4.6 France Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.5 Spain
9.2.5.1 Key Country Dynamics
9.2.5.2 Competitive Scenario
9.2.5.3 Regulatory Framework
9.2.5.4 Reimbursement Scenario
9.2.5.5 Spain Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.6 Italy
9.2.6.1 Key Country Dynamics
9.2.6.2 Target Disease Prevalence
9.2.6.3 Competitive Scenario
9.2.6.4 Regulatory Framework
9.2.6.5 Reimbursement Scenario
9.2.6.6 Italy Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.7 Denmark
9.2.7.1 Key Country Dynamics
9.2.7.2 Target Disease Prevalence
9.2.7.3 Competitive Scenario
9.2.7.4 Regulatory Framework
9.2.7.5 Reimbursement Scenario
9.2.7.6 Denmark Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.8 Sweden
9.2.8.1 Key Country Dynamics
9.2.8.2 Target Disease Prevalence
9.2.8.3 Competitive Scenario
9.2.8.4 Regulatory Framework
9.2.8.5 Reimbursement Scenario
9.2.8.6 Sweden Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.9 Norway
9.2.9.1 Key Country Dynamics
9.2.9.2 Target Disease Prevalence
9.2.9.3 Competitive Scenario
9.2.9.4 Regulatory Framework
9.2.9.5 Reimbursement Scenario
9.2.9.6 Norway Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3 Asia Pacific
9.3.1 Asia Pacific Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.2 Japan
9.3.2.1 Key Country Dynamics
9.3.2.2 Target Disease Prevalence
9.3.2.3 Competitive Scenario
9.3.2.4 Regulatory Framework
9.3.2.5 Reimbursement Scenario
9.3.2.6 Japan Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.3 China
9.3.3.1 Key Country Dynamics
9.3.3.2 Target Disease Prevalence
9.3.3.3 Competitive Scenario
9.3.3.4 Regulatory Framework
9.3.3.5 Reimbursement Scenario
9.3.3.6 China Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.4 India
9.3.4.1 Key Country Dynamics
9.3.4.2 Target Disease Prevalence
9.3.4.3 Competitive Scenario
9.3.4.4 Regulatory Framework
9.3.4.5 Reimbursement Scenario
9.3.4.6 India Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.5 Australia
9.3.5.1 Key Country Dynamics
9.3.5.2 Target Disease Prevalence
9.3.5.3 Competitive Scenario
9.3.5.4 Regulatory Framework
9.3.5.5 Reimbursement Scenario
9.3.5.6 Australia Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.6 Thailand
9.3.6.1 Key Country Dynamics
9.3.6.2 Target Disease Prevalence
9.3.6.3 Competitive Scenario
9.3.6.4 Regulatory Framework
9.3.6.5 Reimbursement Scenario
9.3.6.6 Thailand Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.7 South Korea
9.3.7.1 Key Country Dynamics
9.3.7.2 Target Disease Prevalence
9.3.7.3 Competitive Scenario
9.3.7.4 Regulatory Framework
9.3.7.5 Reimbursement Scenario
9.3.7.6 South Korea Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4 Latin America
9.4.1 Latin America Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.2 Brazil
9.4.2.1 Key Country Dynamics
9.4.2.2 Target Disease Prevalence
9.4.2.3 Competitive Scenario
9.4.2.4 Regulatory Framework
9.4.2.5 Reimbursement Scenario
9.4.2.6 Brazil Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.3 Mexico
9.4.3.1 Key Country Dynamics
9.4.3.2 Target Disease Prevalence
9.4.3.3 Competitive Scenario
9.4.3.4 Regulatory Framework
9.4.3.5 Reimbursement Scenario
9.4.3.6 Mexico Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.4 Argentina
9.4.4.1 Key Country Dynamics
9.4.4.2 Target Disease Prevalence
9.4.4.3 Regulatory Framework
9.4.4.4 Reimbursement Scenario
9.4.4.5 Argentina Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5 MEA
9.5.1 MEA Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.2 South Africa
9.5.2.1 Key Country Dynamics
9.5.2.2 Target Disease Prevalence
9.5.2.3 Competitive Scenario
9.5.2.4 Regulatory Framework
9.5.2.5 Reimbursement Scenario
9.5.2.6 South Africa Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.3 Saudi Arabia
9.5.3.1 Key Country Dynamics
9.5.3.2 Target Disease Prevalence
9.5.3.3 Competitive Scenario
9.5.3.4 Regulatory Framework
9.5.3.5 Reimbursement Scenario
9.5.3.6 Saudi Arabia Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.4 UAE
9.5.4.1 Key Country Dynamics
9.5.4.2 Target Disease Prevalence
9.5.4.3 Competitive Scenario
9.5.4.4 Regulatory Framework
9.5.4.5 Reimbursement Scenario
9.5.4.6 UAE Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.5 Kuwait
9.5.5.1 Key Country Dynamics
9.5.5.2 Target Disease Prevalence
9.5.5.3 Competitive Scenario
9.5.5.4 Regulatory Framework
9.5.5.5 Reimbursement Scenario
9.5.5.6 Kuwait Ngs Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Strategy Mapping
10.3 Company Market Share Analysis, 2023
10.4 Company Profiles
10.4.1 Thermo Fisher Scientific, Inc.
10.4.1.1 Company Overview
10.4.1.2 Life Technologies Corporation
10.4.1.2.1 Company Overview
10.4.1.3 Financial Performance
10.4.1.4 Product Benchmarking
10.4.1.5 Strategic Initiatives
10.4.2 Qiagen N.V.
10.4.2.1 Company Overview
10.4.2.2 Clc Bio
10.4.2.2.1 Company Overview
10.4.2.3 Financial Performance
10.4.2.4 Product Benchmarking
10.4.2.5 Strategic Initiatives
10.4.3 Illumina, Inc.
10.4.3.1 Company Overview
10.4.3.2 Edico Genome
10.4.3.2.1 Company Overview
10.4.3.3 Financial Performance
10.4.3.4 Product Benchmarking
10.4.3.5 Strategic Initiatives
10.4.4 F. Hoffmann-La Roche Ag
10.4.4.1 Company Overview
10.4.4.2 Foundation Medicine
10.4.4.2.1 Company Overview
10.4.4.3 Financial Performance
10.4.4.4 Product Benchmarking
10.4.4.5 Strategic Initiatives
10.4.5 Agilent Technologies, Inc.
10.4.5.1 Company Overview
10.4.5.2 Financial Performance
10.4.5.3 Product Benchmarking
10.4.5.4 Strategic Initiatives
10.4.6 Bio-Rad Laboratories, Inc.
10.4.6.1 Company Overview
10.4.6.2 Gnubio
10.4.6.2.1 Company Overview
10.4.6.3 Financial Performance
10.4.6.4 Product Benchmarking
10.4.6.5 Strategic Initiatives
10.4.7 Pieriandx
10.4.7.1 Company Overview
10.4.7.2 Tute Genomics
10.4.7.2.1 Company Overview
10.4.7.2.2 Knome, Inc.
10.4.7.2.2.1 Company Overview
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 Oxford Nanopore Technologies Plc
10.4.8.1 Company Overview
10.4.8.2 Financial Performance
10.4.8.3 Product Benchmarking
10.4.8.4 Strategic Initiatives
10.4.9 Partek Incorporated
10.4.9.1 Company Overview
10.4.9.2 Product Benchmarking
10.4.9.3 Strategic Initiatives
10.4.10 Eurofins Scientific
10.4.10.1 Company Overview
10.4.10.2 Eurofins Gatc Biotech Gmbh
10.4.10.2.1 Company Overview
10.4.10.3 Financial Performance
10.4.10.4 Product Benchmarking
10.4.10.5 Strategic Initiatives
10.4.11 Dnastar
10.4.11.1 Company Overview
10.4.11.2 Product Benchmarking
10.4.11.3 Strategic Initiatives
10.4.12 Sophia Genetics.
10.4.12.1 Company Overview
10.4.12.2 Financial Performance
10.4.12.3 Product Benchmarking
10.4.12.4 Strategic Initiatives
10.4.13 Fabric Genomics, Inc.
10.4.13.1 Company Overview
10.4.13.2 Financial Performance
10.4.13.3 Product Benchmarking
10.4.13.4 Strategic Initiatives
10.4.14 Laboratory Corporation Of America
10.4.14.1 Company Overview
10.4.14.2 Financial Performance
10.4.14.3 Product Benchmarking
10.4.14.4 Strategic Initiatives
10.4.15 Syapse, Inc.
10.4.15.1 Company Overview
10.4.15.2 Product Benchmarking
10.4.15.3 Strategic Initiatives
10.4.16 Personalis, Inc.
10.4.16.1 Company Overview
10.4.16.2 Financial Performance
10.4.16.3 Product Benchmarking
10.4.16.4 Strategic Initiatives
10.4.17 10x Genomics
10.4.17.1 Company Overview
10.4.17.2 Financial Performance
10.4.17.3 Product Benchmarking
10.4.17.4 Strategic Initiatives
10.4.18 Dnanexus, Inc.
10.4.18.1 Company Overview
10.4.18.2 Product Benchmarking
10.4.18.3 Strategic Initiatives
10.4.19 Centogene N.V.
10.4.19.1 Company Overview
10.4.19.2 Financial Performance
10.4.19.3 Product Benchmarking
10.4.19.4 Strategic Initiatives
10.4.20 Invitae Corporation
10.4.20.1 Company Overview
10.4.20.2 Financial Performance
10.4.20.3 Product Benchmarking
10.4.20.4 Strategic Initiatives
10.4.21 Genedx, Llc
10.4.21.1 Company Overview
10.4.21.2 Financial Performance
10.4.21.3 Product Benchmarking
10.4.21.4 Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Country share estimation
Table 4 Healthcare expenditure
Table 5 NGS top platforms
Table 6 Base pairs sequenced using WGS, WES, and targeted sequencing & resequencing
Table 7 Clonal amplification products in the market
Table 8 North America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 9 North America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 10 North America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 11 North America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 12 North America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 13 North America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 14 North America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 15 North America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 16 North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 17 North America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18 North America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 19 North America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 20 North America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 21 US next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 22 US next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 23 US next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 24 US next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 25 US NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 26 US NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 27 US next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 28 US next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 29 US targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 30 US next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 31 US NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 32 US NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 33 US next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 34 Canada next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 35 Canada next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 36 Canada next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 37 Canada next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 38 Canada NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 39 Canada NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 40 Canada next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 41 Canada next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 42 Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 43 Canada next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 44 Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 45 Canada NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46 Canada next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47 Europe next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 48 Europe next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 49 Europe next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 50 Europe next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 51 Europe NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 52 Europe NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 53 Europe next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 54 Europe next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 55 Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 56 Europe next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 57 Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 58 Europe NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 59 Europe next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 60 Germany next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 61 Germany next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 62 Germany next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 63 Germany next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 64 Germany NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 65 Germany NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 66 Germany next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 67 Germany next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 68 Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 69 Germany next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 70 Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 71 Germany NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 72 Germany next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 73 UK next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 74 UK next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 75 UK next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 76 UK next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 77 UK NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 78 UK NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 79 UK next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 80 UK next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 81 UK targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 82 UK next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 83 UK NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 84 UK NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 85 UK next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 86 Spain next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 87 Spain next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 88 Spain next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 89 Spain next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 90 Spain NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 91 Spain NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 92 Spain next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 93 Spain next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 94 Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 95 Spain next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 96 Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 97 Spain NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 98 Spain next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 99 France next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 100 France next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 101 France next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 102 France next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 103 France NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 104 France NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 105 France next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 106 France next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 107 France targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 108 France next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 109 France NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 110 France NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 111 France next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 112 Italy next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 113 Italy next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 114 Italy next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 115 Italy next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 116 Italy NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 117 Italy NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 118 Italy next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 119 Italy next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 120 Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 121 Italy next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 122 Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 123 Italy NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 124 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 125 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 126 Denmark next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 127 Denmark next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 128 Denmark next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 129 Denmark next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 130 Denmark NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 131 Denmark NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 132 Denmark next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 133 Denmark next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 134 Denmark targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 135 Denmark next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 136 Denmark NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 137 Denmark NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 138 Denmark next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 139 Norway next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 140 Norway next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 141 Norway next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 142 Norway next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 143 Norway NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 144 Norway NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 145 Norway next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 146 Norway next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 147 Norway targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 148 Norway next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 149 Norway NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 150 Norway NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 151 Norway next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 152 Sweden next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 153 Sweden next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 154 Sweden next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 155 Sweden next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 156 Sweden NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 157 Sweden NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 158 Sweden next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 159 Sweden next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 160 Sweden targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 161 Sweden next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 162 Sweden NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 163 Sweden NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 164 Sweden next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 165 Asia Pacific next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 166 Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 167 Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 168 Asia Pacific next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 169 Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 170 Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 171 Asia Pacific next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 172 Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 173 Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 174 Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 175 Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 176 Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 177 Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 178 Japan next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 179 Japan next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 180 Japan next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 181 Japan next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 182 Japan NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 183 Japan NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 184 Japan next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 185 Japan next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 186 Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 187 Japan next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 188 Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 189 Japan NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 190 Japan next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 191 China next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 192 China next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 193 China next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 194 China next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 195 China NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 196 China NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 197 China next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 198 China next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 199 China targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 200 China next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 201 China NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 202 China NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 203 China next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 204 India next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 205 India next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 206 India next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 207 India next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 208 India NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 209 India NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 210 India next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 211 India next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 212 India targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 213 India next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 214 India NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 215 India NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 216 India next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 217 South Korea next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 218 South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 219 South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 220 South Korea next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 221 South Korea NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 222 South Korea NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 223 South Korea next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 224 South Korea next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 225 South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 226 South Korea next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 227 South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 228 South Korea NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 229 South Korea next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 230 Australia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 231 Australia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 232 Australia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 233 Australia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 234 Australia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 235 Australia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 236 Australia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 237 Australia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 238 Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 239 Australia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 240 Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 241 Australia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 242 Australia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 243 Thailand next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 244 Thailand next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 245 Thailand next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 246 Thailand next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 247 Thailand NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 248 Thailand NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 249 Thailand next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 250 Thailand next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 251 Thailand targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 252 Thailand next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 253 Thailand NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 254 Thailand NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 255 Thailand next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 256 Latin America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 257 Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 258 Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 259 Latin America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 260 Latin America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 261 Latin America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 262 Latin America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 263 Latin America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 264 Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 265 Latin America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 266 Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 267 Latin America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 268 Latin America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 269 Brazil next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 270 Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)

※본 조사보고서 [세계의 차세대 시퀀싱 (NGS) 시장 2024-2030 : 기술별 (WGS, 타겟 시퀀싱, 리시퀀싱), 제품별 (플랫폼, 소모품), 용도별, 워크플로우별, 최종 용도별, 지역별] (코드 : GRV24JAN048) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 차세대 시퀀싱 (NGS) 시장 2024-2030 : 기술별 (WGS, 타겟 시퀀싱, 리시퀀싱), 제품별 (플랫폼, 소모품), 용도별, 워크플로우별, 최종 용도별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 타겟 시퀀싱 및 리시퀀싱 시장 (2023~2030) : NGS, 기타
GRV23MR040 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 타겟 시퀀싱 및 리시퀀싱 시장 규모가 2023년부터 2030년 사이에 CAGR 22.59% 증가하여, 2030년에는 257억 달러에 달할 것으로 전망하고 있습니다. 본 조사...Targeted Sequencing And Resequencing Market Growth & Trends The global targeted sequencing and resequencing market size is expected to reach USD 25.7 billion expanding at a CAGR of 22.59% from 2023 to 2030, according to a new report by Grand View Research, Inc. Owing to the continuous technological developments in...

세계의 차세대 시퀀싱 (NGS) 서비스 시장 2024-2030 : 서비스 유형별 (인간 게놈 시퀀싱, 유전자 제어 서비스), 워크플로우별, 최종 용도별, 지역별
GRV24JAN049 / Grand View Research / 2023년 11월 / 글로벌 차세대 시퀀싱 (NGS) 서비스 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 차세대 시퀀싱 서비스 시장 규모는 2030년까지 244억 8천만 달러에 달할 것으로 예상되며, 2024년부터 2030년까지...1. 조사 방법 및 범위 2. 개요 3. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 변수/동향/범위 4. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 서비스 유형별 비즈니스 분석 5. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 워크플로우별 비즈니스 분석 6. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 최종...

세계의 차세대 시퀀싱 (NGS) 서비스 시장 2023-2030 : 유형별 (인간 게놈 시퀀싱, 단일 세포 시퀀싱, 미생물 게놈 기반 시퀀싱, 기타), 워크플로우별 (사전 시퀀싱, 시퀀싱, 데이터 분석), 최종 용도별 (대학 및 기타 연구 기관, 병원 및 클리닉, 기타), 지역별
BZW24FEB070 / Bizwit Research & Consulting / 2024年1月 / 세계의 차세대 시퀀싱 (NGS) 서비스 시장은 2022년 약 4.8억 달러로 평가되며, 예측 기간인 2023년부터 2030년까지 22.68% 이상의 견조한 성장률을 기록할 것으로 예상됩니다. 차세대 시퀀싱 (NGS) 서비스에는 전문 서비스 제공업체가 제공하는...1. 개요 2. 시장 정의 및 범위 3. 시장 동향 4. 산업 분석 5. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 유형별 6. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 워크플로우별 7. 세계의 차세대 시퀀싱 (NGS) 서비스 시장 규모 : 최종 용도별 8. 세계의 차세대 시퀀싱 (NGS) 서비스...

글로벌 펩티드 약물 복합체 시장 (2023-2030) : 루테튬, 멜플루펜, ANG1005, BT1718, CBX-12, 기타 파이프 라인
GRV23NOV280 / Grand View Research / 2023년 9월 / 글로벌 펩타이드 약물 복합체 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 펩타이드 약물 복합체 시장은 2030년까지 42억 1000만 달러에 달할 것으로 예상되며, 예측 기간 동안 28. 58%의...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 펩티드 약물 복합체 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 펩티드 약물 복합체 시장 : 제품별 예측 및 동향 분석 Chapter 6. 세계의 펩티드 약물 복합체 시장 : 지역별...

세계의 에리스로포이에틴 제제 시장 (2023~2030) : 생물 제제, 바이오시밀러
GRV23MR091 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 에리스로포이에틴 제제 시장 규모가 2023년부터 2030년 사이에 CAGR 1.5% 증가하여, 2030년에는 78억 달러에 달할 것으로 전망하고 있습니다. 본 조사 자료는 세계의...Erythropoietin Drugs Market Growth & Trends The global erythropoietin drugs market size is expected to reach USD 7.8 billion expanding at a CAGR of 1.5% from 2023 to 2030, according to a new report by Grand View Research, Inc., The slow growth can be attributed to the patent expiry of...